Professor, Pathology and Laboratory Medicine, UCLA School of Medicine
Pathology
Dr. Charles R. Lassman, MD
|
|
Give Review
Charles Lassman is an expert in the field of Pathology. He attended University of Pittsburgh School of Medicine. Doctor Charles R. Lassman, MD is a published MD. He has 74 papers published. The most current publication "Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy." He accepts all Medicare patients.
Publications
- Contrast Enhancement Patterns after Irreversible Electroporation: Experimental Study of CT Perfusion Correlated to Histopathology in Normal Porcine Liver.
- Novel liver findings in ornithine transcarbamylase deficiency due to Xp11.4-p21.1 microdeletion.
- Assessment of Chronological Effects of Irreversible Electroporation on Hilar Bile Ducts in a Porcine Model.
- Abdominal imaging can misdiagnose submassive hepatic necrosis as cirrhosis in acute liver failure.
- Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features.
- Hepatitis C-Associated Cryoglobulinemic Glomerulonephritis With Crystalline Deposits.
- Assessment of hepatic steatosis by transplant surgeon and expert pathologist a prospective, double-blind evaluation of 201 donor livers.
- Twenty-four years after liver transplantation, the recipient becomes a body donor.
- Total parenteral nutrition therapy and liver injury: a histopathologic study with clinical correlation.
- Extramedullary acute myelocytic leukemia following liver transplantation for VOD with immunodeficiency.
- Apolipoprotein A1 and C-terminal fragment of ?-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection.
- Focal nodular hyperplasia after orthotopic liver transplantation.
- Recurrent hepatic lymphangiomatosis after orthotopic liver transplantation.
- Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model.
- Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts.
- Inflammatory responses in a new mouse model of prolonged hepatic cold ischemia followed by arterialized orthotopic liver transplantation.
- C4d staining of pulmonary allograft biopsies: an immunoperoxidase study.
- Outcomes of acute rejection after interferon therapy in liver transplant recipients.
- Interleukin-13 gene transfer protects rat livers from antigen-independent injury induced by ischemia and reperfusion.
- Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection.
- Deeper examination of negative colorectal biopsies.
- Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with posttransplant lymphoproliferative disease.
- Histopathological features of hepatitis C in renal transplant candidates [see comment].
- FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration.
- Donor and recipient outcomes in right lobe adult living donor liver transplantation.
- P-selectin glycoprotein ligand-1 (rPSGL-Ig)-mediated blockade of CD62 selectin molecules protects rat steatotic liver grafts from ischemia/reperfusion injury.
- Regulated expression of the mouse gamma 2b Ig H chain gene is influenced by polyA site order and strength.
- Plasma cell-regulated polyadenylation at the Ig gamma 2b secretion-specific poly(A) site.
- Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury.
- Minimizing diaphragmatic injury during radio-frequency ablation: efficacy of subphrenic peritoneal saline injection in a porcine model.
- Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect.
- Intraoperative triple antenna hepatic microwave ablation.
- Liver biopsy interpretation for causes of late liver allograft dysfunction.
- CXCR3+CD4+ T cells mediate innate immune function in the pathophysiology of liver ischemia/reperfusion injury.
- Hepatocellular carcinoma: microwave ablation with multiple straight and loop antenna clusters--pilot comparison with pathologic findings.
- Fulminant hepatic failure from primary hepatic lymphoma: successful treatment with orthotopic liver transplantation and chemotherapy.
- Disruption of P-selectin signaling modulates cell trafficking and results in improved outcomes after mouse warm intestinal ischemia and reperfusion injury.
- Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C.
- Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury.
- Cytoprotective and antiapoptotic effects of IL-13 in hepatic cold ischemia/reperfusion injury are heme oxygenase-1 dependent.
- Minimizing central bile duct injury during radiofrequency ablation: use of intraductal chilled saline perfusion--initial observations from a study in pigs.
- Minimizing diaphragmatic injury during radiofrequency ablation: efficacy of intraabdominal carbon dioxide insufflation.
- Fulminant liver failure due to usnic acid for weight loss.
- Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings.
- Kidney transplantation at UCLA.
- Biliverdin therapy protects rat livers from ischemia and reperfusion injury.
- Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different models.
- Intraductal oncocytic papillary neoplasm of the liver: case and review of a rare variant.
- Microwave liver ablation: influence of hepatic vein size on heat-sink effect in a porcine model.
- Differential impact of CD154 costimulation blockade on alloreactive effector and regulatory T cells in murine renal transplant recipients.
- CXCL10 regulates liver innate immune response against ischemia and reperfusion injury.
- Type I Interferon Pathway Mediates Renal Ischemia/Reperfusion Injury.
- Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma.
- CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.
- Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis.
- Diffuse cirrhosis-like hepatocellular carcinoma: a clinically and radiographically undetected variant mimicking cirrhosis.
- Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA.
- A caspase inhibitor, IDN-6556, ameliorates early hepatic injury in an ex vivo rat model of warm and cold ischemia.
- Type III mixed cryoglobulinemia and antiphospholipid syndrome in a patient with partial DiGeorge syndrome.
- Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.
- Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction.
- Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
- Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway.
- Renal clear-cell carcinoma: an ultrastructural study on the junctional complexes.
- Biliverdin protects rat livers from ischemia/reperfusion injury.
- Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury.
- A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.
- Hepatocyte growth factor receptor in acute tubular necrosis.
- Creation of radiofrequency lesions in a porcine model: correlation with sonography, CT, and histopathology.
- Cyclosporine and tacrolimus-associated thrombotic microangiopathy.
- Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
- FTY720: a novel approach to the treatment of hepatic ischemia-reperfusion injury.
- Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An ...
Schools
University of Pittsburgh Main Campus
Doctors Specialties
- Anatomic Pathology
- Pathology
Accepted Insurances
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select Plus HMO
- Select PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Delta Health System
- First Health (Coventry Health Care) PPO
- Guardian
- Blue & Gold HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Medicare MCR
- Heritage Signature
- Priority Health
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Education
-
Stanford University -
University of Pittsburgh School of Medicine
Hospital
-
Harbor-UCLA Medical Center -
LAC-Olive View-UCLA Medical Center -
Ronald Reagan UCLA Medical Center -
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1912932708 |
| Last Name Of The Provider | LASSMAN |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
|
Dr. Moacyr M. Da Silva Jr., MD |
|
|
Dr. Samuel W. French, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph A. Dubeau, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Michael R. Lieber, MD |
|
|
Dr. Min Huang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nora L. Ostrzega, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kiva T. Iverson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Avram A. Jacobson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laurence J. Purdy, MD |
|
|
Dr. Andy E. Sherrod, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy J. Triche, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alyssa F. Ziman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William W. Temple Jr., MD
This Doctor is OpenDoctor Recommended.
|